The advancement, made possible by tiny photonic implants, could lead to new treatments for cancer, mental disorders
It seems like everything is going wireless these days. That now includes efforts to reprogram the human genome.
A new University at Buffalo-led study describes how researchers wirelessly controlled FGFR1 — a gene that plays a key role in how humans grow from embryos to adults — in lab-grown brain tissue.
The ability to manipulate the gene, the study’s authors say, could lead to new cancer treatments, and ways to prevent and treat mental disorders such as schizophrenia.
The work — spearheaded by UB researchers Josep M. Jornet, Michal K. Stachowiak, Yongho Bae and Ewa K. Stachowiak — was reported in the June edition of the Proceedings of the Institute of Electrical and Electronics Engineers.
It represents a step forward toward genetic manipulation technology that could upend the treatment of cancer, as well as the prevention and treatment of schizophrenia and other neurological illnesses. It centers on the creation of a new subfield of research the study’s authors are calling “optogenomics,” or controlling the human genome through laser light and nanotechnology.
“The potential of optogenomic interfaces is enormous,” says co-author Josep M. Jornet, PhD, associate professor in the Department of Electrical Engineering in the UB School of Engineering and Applied Sciences. “It could drastically reduce the need for medicinal drugs and other therapies for certain illnesses. It could also change how humans interact with machines.”
From “optogenetics” to “optogenomics”
For the past 20 years, scientists have been combining optics and genetics — the field of optogenetics — with a goal of employing light to control how cells interact with each other.
By doing this, one could potentially develop new treatments for diseases by correcting the miscommunications that occur between cells. While promising, this research does not directly address malfunctions in genetic blueprints that guide human growth and underlie many diseases.
The new research begins to tackle this issue because FGFR1 — it stands for Fibroblast Growth Factor Receptor 1 — holds sway over roughly 4,500 other genes, about one-fifth of the human genome, as estimated by the Human Genome Project, says study co-author Michal K. Stachowiak.
“In some respects, it’s like a boss gene,” says Stachowiak, PhD, professor in the Department of Pathology and Anatomical Sciences in the Jacobs School of Medicine and Biomedical Sciences at UB. “By controlling FGFR1, one can theoretically prevent widespread gene dysregulations in schizophrenia or in breast cancer and other types of cancer.”
Light-activated toggle switches
The research team was able to manipulate FGFR1 by creating tiny photonic brain implants. These wireless devices include nano-lasers and nano-antennas and, in the future, nano-detectors.
Researchers inserted the implants into the brain tissue, which was grown from induced pluripotent stem cells and enhanced with light-activated molecular toggle switches. They then triggered different laser lights — common blue laser, red laser and far-red laser — onto the tissue.
The interaction allowed researchers to activate and deactivate FGFR1 and its associated cellular functions — essentially hacking the gene. The work may eventually enable doctors to manipulate patients’ genomic structure, providing a way to prevent and correct gene abnormalities, says Stachowiak, who also holds an appointment in UB’s Department of Biomedical Engineering, a joint program between the Jacobs School and UB’s engineering school.
The development is far from entering the doctor’s office or hospital, but the research team is excited about next steps, which include testing in 3D “mini-brains” and cancerous tissue.
The Latest on: Reprogramming the human genome
via Google News
The Latest on: Reprogramming the human genome
- Is It the Junk [DNA] That Makes Our Brains Human?on October 12, 2021 at 9:30 am
Scientists have long sought to understand what makes us human. From the standpoint of DNA sequences, we have a lot in common with our closest evolutionary | Cell And Molecular Biology ...
- Plant Detectives Develop Tool to Track Spread of Major Crop Diseaseon October 7, 2021 at 5:00 pm
With more research, it can be applied to track human, animal, and foodborne illnesses ... in Agrobacterium as they have genes that allow it to essentially “genetically reprogram” the host plant to ...
- U.S.’ top scientist to step down at NIHon October 5, 2021 at 11:32 am
Francis Collins, perhaps one of the U.S.’ biggest cheerleaders for the promise of medical science, announced Oct. 5 that he will be ending his 12-year tenure as NIH director by the end of the year, ...
- Induced Pluripotent Stem Cells Market – Growing Focus on Personalized Regenerative Cell Therapies Drive the Marketon October 4, 2021 at 11:48 pm
Over the past few years, researchers have come out with several clinically important changes in reprogramming process; a case in point is silencing retroviruses in the human genome. Molecular ...
- Sequencing newly replicated DNA reveals widespread plasticity in human replication timingon October 4, 2021 at 2:33 pm
Faithful transmission of genetic material to daughter cells involves a characteristic temporal order of DNA replication, which may play a significant role in the inheritance of epigenetic states. We ...
- Zaki syndrome - Pediatric Disorder & Potential Treatment ID'edon October 4, 2021 at 8:17 am
Since it's become quick and relatively inexpensive to sequence a human genome, researchers have gained unprecedented and rapid insight into genetic diseases that arise in rare cases. An international ...
- Kurzweil on Why Medicine Is Undergoing a Grand Transformationon October 3, 2021 at 4:59 pm
The sequencing of the human genome has transitioned the practice of medicine into ... Our ability to understand and model this data and to simulate and to reprogram this ancient software is also ...
- Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogrammingon October 2, 2021 at 7:40 pm
Current DNA methylation assays are limited in the flexibility and efficiency of characterizing a large number of genomic targets. We report a method to specifically capture an arbitrary subset of ...
- Bio-Techne Launches ExCellerate™ iPSC Expansion Mediumon September 14, 2021 at 8:20 am
A novel animal component-free medium that supports robust expansion and maintenance of human pluripotent stem ... including cell isolation, reprogramming, genome engineering, cell expansion ...
via Bing News